NCT06667037 Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control
| NCT ID | NCT06667037 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zhongshan Ophthalmic Center, Sun Yat-sen University |
| Condition | Myopia |
| Study Type | INTERVENTIONAL |
| Enrollment | 194 participants |
| Start Date | 2024-09-21 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 194 participants in total. It began in 2024-09-21 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this multicenter randomized clinical trial is to evaluate the myopia control effect of orthokeratology and 0.01% atropine sequential treatment in children and adolescents, as compared to continuous treatment with orthokeratology.
Eligibility Criteria
Inclusion Criteria: 1. Aged 8-15 years old. 2. Spherical equivalent refractions (SERs) -0.50 to -6.00 Dioptres (D) and astigmatism less than -1.5 D in both eyes, anisometropia less than 1.5 D. 3. Best corrected visual acuity (BCVA) equal to or better than 20/25 in both eyes. 4. Bilateral intra-ocular pressure \< 21mmHg. 5. Normal binocular and stereoscopic visual function. 6. Participants and their guardians' understanding and acceptance of random allocation of grouping. Exclusion Criteria: 1. Manifest strabismus, except for intermittent tropia. 2. Ocular or systemic diseases which may affect vision or refractive error. 3. Previous use of myopia control without washout, including atropine, myopia control spectacles, myopia control contact lenses. 4. Other contraindications.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06667037 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 15 Years, studying Myopia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06667037 currently recruiting?
Yes, NCT06667037 is actively recruiting participants. Contact the research team at eddy06980094@163.com for enrollment information.
Where is the NCT06667037 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT06667037 clinical trial?
NCT06667037 is sponsored by Zhongshan Ophthalmic Center, Sun Yat-sen University. The trial plans to enroll 194 participants.